Stay updated on Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.

Latest updates to the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision line updated to v3.3.2, replacing the previous v3.3.1. This update does not alter study details, eligibility, or outcome data.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1; there are no changes to the study details, eligibility criteria, or results sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check26 days agoChange Detected- A government funding status notice/banner that warned users about potential delays has been removed from the page. - This banner was a site-wide informational message and does not affect the displayed study details or eligibility criteria.SummaryDifference0.3%

- Check40 days agoChange DetectedNo significant changes detected on the Study Details page. The content remains the same as the existing record for NCT03041688.SummaryDifference0.3%

- Check68 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference2%

- Check76 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.